Effective use of transdermal drug delivery in children.

[1]  I. Alberti,et al.  Next generation intra- and transdermal therapeutic systems: using non- and minimally-invasive technologies to increase drug delivery into and across the skin. , 2013, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[2]  A. Irvine,et al.  Newborn Transepidermal Water Loss Values: A Reference Dataset , 2013, Pediatric dermatology.

[3]  Fiona L. R. Williams,et al.  A systematic review of thyroid dysfunction in preterm neonates exposed to topical iodine , 2013, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[4]  V. Piccolo,et al.  Hair in newborns and infants: clinical and dermoscopic evaluation of 45 cases , 2013, The British journal of dermatology.

[5]  Mark R Prausnitz,et al.  Faster pharmacokinetics and increased patient acceptance of intradermal insulin delivery using a single hollow microneedle in children and adolescents with type 1 diabetes , 2013, Pediatric diabetes.

[6]  A. Watkinson.  A commentary on transdermal drug delivery systems in clinical trials. , 2013, Journal of pharmaceutical sciences.

[7]  A. Singal,et al.  Perniosis in an Infant Treated with Topical Nitroglycerine , 2013, Pediatric dermatology.

[8]  S. Aucott,et al.  Absorption and Tolerability of Aqueous Chlorhexidine Gluconate Used for Skin Antisepsis Prior to Catheter Insertion in Preterm Neonates , 2013, Journal of Perinatology.

[9]  T. Ichikawa,et al.  Long-term safety, efficacy, and patient acceptability of the tulobuterol patch , 2013 .

[10]  S. Balachandar,et al.  Exogenous pubertal induction by oral versus transdermal estrogen therapy. , 2013, Journal of pediatric and adolescent gynecology.

[11]  R. Riccardi,et al.  Efficacy and safety of transdermal buprenorphine in the management of children with cancer‐related pain , 2013, Pediatric blood & cancer.

[12]  K. Allegaert,et al.  The propylene glycol research project to illustrate the feasibility and difficulties to study toxicokinetics in neonates. , 2012, International journal of pharmaceutics.

[13]  S. Prapaitrakool,et al.  Use of buprenorphine in children with chronic pseudoobstruction syndrome: case series and review of literature. , 2012, The Clinical journal of pain.

[14]  M. Delgado-Charro,et al.  Passive and iontophoretic transdermal delivery of phenobarbital: Implications in paediatric therapy. , 2012, International journal of pharmaceutics.

[15]  R. Guy,et al.  Transdermal iontophoresis of ranitidine: an opportunity in paediatric drug therapy. , 2012, International journal of pharmaceutics.

[16]  A. Smits,et al.  Biochemical tolerance during low dose propylene glycol exposure in neonates: A formulation-controlled evaluation , 2012, DARU Journal of Pharmaceutical Sciences.

[17]  J. Hadgraft,et al.  Toxicological implications of the delivery of fentanyl from gel extracted from a commercial transdermal reservoir patch. , 2012, Toxicology in vitro : an international journal published in association with BIBRA.

[18]  R. Guy.  Transdermal drug delivery. , 2012, Handbook of experimental pharmacology.

[19]  A. Kissenpfennig,et al.  Microneedle-mediated vaccine delivery: Harnessing cutaneous immunobiology to improve efficacy , 2012, Expert opinion on drug delivery.

[20]  S. Wigal,et al.  Metabolic, toxicological, and safety considerations for drugs used to treat ADHD , 2012, Expert opinion on drug metabolism & toxicology.

[21]  S. Shin,et al.  Availability of a 5% lidocaine patch used prophylactically for venipuncture- or injection-related pain in children , 2012, Journal of Anesthesia.

[22]  B. Anderson,et al.  Perioperative management of the child on long‐term opioids , 2012, Paediatric anaesthesia.

[23]  R. Darlenski,et al.  Infant epidermal skin physiology: adaptation after birth , 2012, The British journal of dermatology.

[24]  Y. Kwak,et al.  The effect of SonoPrep® on EMLA® cream application for pain relief prior to intravenous cannulation , 2012, European Journal of Pediatrics.

[25]  M. Rao,et al.  Effectiveness of dexamethasone iontophoresis for temporomandibular joint involvement in juvenile idiopathic arthritis , 2011, Arthritis care & research.

[26]  J. Ghuman,et al.  Methylphenidate transdermal system in preschool children with attention-deficit/hyperactivity disorder. , 2011, Journal of child and adolescent psychopharmacology.

[27]  C. Dubray,et al.  Echographic measurement of skin thickness in sites suitable for intradermal vaccine injection in infants and children. , 2011, Vaccine.

[28]  C. Tuleu,et al.  Needle-free and microneedle drug delivery in children: a case for disease-modifying antirheumatic drugs (DMARDs). , 2011, International journal of pharmaceutics.

[29]  Lisa Szatkowski,et al.  Prescribing of nicotine replacement therapy to adolescents in England. , 2011, Addiction.

[30]  M. Garland,et al.  Microneedle arrays as medical devices for enhanced transdermal drug delivery , 2011, Expert review of medical devices.

[31]  Y. Kalia,et al.  Human growth hormone: new delivery systems, alternative routes of administration, and their pharmacological relevance. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[32]  Patricia A. McKenna,et al.  Methylphenidate transdermal system: clinical applications for attention-deficit/hyperactivity disorder , 2011, Expert review of clinical pharmacology.

[33]  E. Eugster,et al.  Medical care of girls with Turner Syndrome: where are we lacking? , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[34]  Mark R Prausnitz,et al.  Rapid pharmacokinetics of intradermal insulin administered using microneedles in type 1 diabetes subjects. , 2011, Diabetes technology & therapeutics.

[35]  B. Anderson,et al.  Buprenorphine TTS for children – a review of the drug’s clinical pharmacology , 2011, Paediatric anaesthesia.

[36]  V. Narendran,et al.  Neonatal Skin Maturation—Vernix Caseosa and Free Amino Acids , 2011, Pediatric dermatology.

[37]  H. Seo,et al.  Effectiveness of pharmacologic therapy for smoking cessation in adolescent smokers: Meta-analysis of randomized controlled trials. , 2011, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[38]  N. Kollias,et al.  Infant skin physiology and development during the first years of life: a review of recent findings based on in vivo studies , 2011, International journal of cosmetic science.

[39]  E. Dietz,et al.  Follicular and percutaneous penetration pathways of topically applied minoxidil foam. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[40]  X. Soria,et al.  Chlorhexidine‐Methanol Burns in Two Extreme Preterm Newborns , 2010, Pediatric dermatology.

[41]  P. Kranke,et al.  Transdermal scopolamine for the prevention of postoperative nausea and vomiting: a systematic review and meta-analysis. , 2010, Clinical therapeutics.

[42]  A. Rapoport.  Sublingual atropine drops for the treatment of pediatric sialorrhea. , 2010, Journal of pain and symptom management.

[43]  D. Pierce,et al.  Single- and Multiple-Dose Pharmacokinetics of Methylphenidate Administered as Methylphenidate Transdermal System or Osmotic-Release Oral System Methylphenidate to Children and Adolescents With Attention Deficit Hyperactivity Disorder , 2010, Journal of clinical psychopharmacology.

[44]  S. W. Halpern,et al.  Contribution of a heating element to topical anesthesia patch efficacy prior to vascular access: results from two randomized, double-blind studies. , 2010, Journal of pain and symptom management.

[45]  L. Eichenfield,et al.  The Safety and Efficacy of Tacrolimus Ointment in Pediatric Patients with Atopic Dermatitis , 2010, Pediatric dermatology.

[46]  E. Berardesca,et al.  Functional skin adaptation in infancy – almost complete but not fully competent , 2010, Experimental dermatology.

[47]  F. Afsar.  Physiological skin conditions of preterm and term neonates , 2010, Clinical and experimental dermatology.

[48]  G. Molter,et al.  [Topical anesthesia before vascular access in children. Comparison of a warmth-producing lidocaine-tetracaine patch with a lidocaine-prilocaine patch]. , 2010, Der Anaesthesist.

[49]  P. Teschendorf,et al.  Topische Anästhesie vor Venenpunktion bei Kindern , 2010, Der Anaesthesist.

[50]  R. Sutter,et al.  Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba. , 2010, The Journal of infectious diseases.

[51]  R. Donnelly,et al.  Microneedle-based drug delivery systems: Microfabrication, drug delivery, and safety , 2010, Drug delivery.

[52]  H. Panitch,et al.  Pulmonary complications of pediatric neurological diseases. , 2010, Pediatric annals.

[53]  G. Somes,et al.  Gender, smoking status, and risk behavior attitudes explain adolescents' patterns of nicotine replacement therapy use. , 2010, Addictive behaviors.

[54]  H. Maibach,et al.  Measuring transepidermal water loss: a comparative in vivo study of condenser‐chamber, unventilated‐chamber and open‐chamber systems , 2009, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[55]  M. Nahata.  Safety of “inert” additives or excipients in paediatric medicines , 2009, Archives of Disease in Childhood: Fetal and Neonatal Edition.

[56]  R. Findling,et al.  Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials. , 2009, Clinical therapeutics.

[57]  L. Dimeglio,et al.  Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study. , 2009, The Journal of clinical endocrinology and metabolism.

[58]  O. Bukstein.  Transdermal methylphenidate system: old wine in a new bottle , 2009, Expert opinion on drug metabolism & toxicology.

[59]  M. E. P. de Jesus,et al.  Closed‐chamber transepidermal water loss measurement: microclimate, calibration and performance , 2009, International journal of cosmetic science.

[60]  M. Ashburn,et al.  Heated lidocaine/tetracaine patch (Synera, Rapydan) compared with lidocaine/prilocaine cream (EMLA) for topical anaesthesia before vascular access. , 2009, British journal of anaesthesia.

[61]  Mario A. González,et al.  Evolution of stimulants to treat ADHD: transdermal methylphenidate , 2009, Human psychopharmacology.

[62]  Michael A. Miller,et al.  Transdermal Patch Medication Delivery Systems and Pediatric Poisonings, 2002-2006 , 2008, Clinical pediatrics.

[63]  J. McGough,et al.  Pharmacokinetics of methylphenidate transdermal system (MTS): results from a laboratory classroom study. , 2008, Journal of child and adolescent psychopharmacology.

[64]  T. Tanner,et al.  Delivering drugs by the transdermal route: review and comment , 2008, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[65]  B. Taira,et al.  Warm lidocaine/tetracaine patch versus placebo before pediatric intravenous cannulation: a randomized controlled trial. , 2008, Annals of emergency medicine.

[66]  N. Kollias,et al.  Barrier function and water-holding and transport properties of infant stratum corneum are different from adult and continue to develop through the first year of life. , 2008, The Journal of investigative dermatology.

[67]  T. Wilens,et al.  Varying the wear time of the methylphenidate transdermal system in children with attention-deficit/hyperactivity disorder. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[68]  R. Kauffman,et al.  Needle-Free Powder Lidocaine Delivery System Provides Rapid Effective Analgesia for Venipuncture or Cannulation Pain in Children: Randomized, Double-Blind Comparison of Venipuncture and Venous Cannulation Pain After Fast-Onset Needle-Free Powder Lidocaine or Placebo Treatment Trial , 2008, Pediatrics.

[69]  M. Tachi,et al.  Mass spectrometric characterization of cholesterol esters and wax esters in epidermis of fetal, adult and keloidal human skin , 2008, Experimental dermatology.

[70]  E. Warshaw,et al.  Practical management of cutaneous reactions to the methylphenidate transdermal system: recommendations from a dermatology expert panel consensus meeting. , 2008, Clinical therapeutics.

[71]  K. Emmons,et al.  Developing smoking cessation programs for chronically ill teens: lessons learned from research with healthy adolescent smokers. , 2007, Journal of pediatric psychology.

[72]  R. Guy,et al.  Quantitative structure-permeation relationship for iontophoretic transport across the skin. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[73]  B. Anderson,et al.  Transdermal fentanyl in childhood and adolescence: a comprehensive literature review. , 2007, The journal of pain : official journal of the American Pain Society.

[74]  A. Hussain,et al.  Transdermal drug delivery system (TDDS) adhesion as a critical safety, efficacy and quality attribute. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[75]  A. Singer,et al.  Laser-assisted anesthesia reduces the pain of venous cannulation in children and adults: a randomized controlled trial. , 2006, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[76]  D. Calhoun,et al.  Recent Advances in Neonatal Pharmacotherapy , 2006, The Annals of pharmacotherapy.

[77]  A. Lynn,et al.  A Comparison of a Needle-Free Injection System for Local Anesthesia Versus EMLA® for Intravenous Catheter Insertion in the Pediatric Patient , 2006, Anesthesia and analgesia.

[78]  L. Zeltzer,et al.  Transdermal fentanyl in the management of children with chronic severe pain , 2005, Cancer.

[79]  Samir Mitragotri,et al.  Immunization without needles , 2005, Nature Reviews Immunology.

[80]  M. Migdał,et al.  Rapid, Needle-Free Delivery of Lidocaine for Reducing the Pain of Venipuncture Among Pediatric Subjects , 2005, Pediatrics.

[81]  H. Maibach,et al.  The correlation between transepidermal water loss and percutaneous absorption: an overview. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[82]  T. Shwayder,et al.  Neonatal skin barrier: structure, function, and disorders , 2005, Dermatologic therapy.

[83]  D. Zurakowski,et al.  A Randomized Controlled Trial to Evaluate S-Caine Patch™ for Reducing Pain Associated with Vascular Access in Children , 2005, Anesthesiology.

[84]  Y. Kalia,et al.  Development of an in vitro model for premature neonatal skin: biophysical characterization using transepidermal water loss. , 2004, Journal of pharmaceutical sciences.

[85]  Y. Kalia,et al.  Porcine Ear Skin as a Model for the Assessment of Transdermal Drug Delivery to Premature Neonates , 2004, Pharmaceutical Research.

[86]  H. Omar,et al.  Long-Term Evaluation of the Use of the Transdermal Contraceptive Patch in Adolescents , 2004, TheScientificWorldJournal.

[87]  Mahmoud Ameri,et al.  Transdermal delivery of desmopressin using a coated microneedle array patch system. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[88]  U. Blume-Peytavi,et al.  Stratum Corneum Maturation , 2004, Skin Pharmacology and Physiology.

[89]  L. Sirota,et al.  Disinfection with 10% povidone‐iodine versus 0.5% chlorhexidine gluconate in 70% isopropanol in the neonatal intensive care unit , 2004, Acta paediatrica.

[90]  G. Kearns,et al.  Percutaneous lidocaine administration via a new iontophoresis system in children: tolerability and absence of systemic bioavailability. , 2003, Pediatrics.

[91]  D. Hatsukami,et al.  Treatment of adolescent smokers with the nicotine patch. , 2003, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[92]  A. Sintov,et al.  Transdermal delivery of paracetamol for paediatric use: effects of vehicle formulations on the percutaneous penetration , 2003, The Journal of pharmacy and pharmacology.

[93]  C. Byrne,et al.  Skin Structural Development , 2003 .

[94]  L. Greenhill,et al.  Pharmacokinetics (PK) Effectiveness (E) and Tolerability (T) of Transdermal Selegiline (STS) in Children (C) and Adolescents (A) with Attention Deficit Hyperactivity Disorder (ADHD) , 2003 .

[95]  D. Laskin,et al.  Transdermal Xenobiotics in Newborn Skin , 2003, Journal of toxicology. Cutaneous and ocular toxicology.

[96]  H. Chase,et al.  Use of the GlucoWatch® biographer in children and adolescents with diabetes , 2002, Pediatric diabetes.

[97]  J. Galinkin,et al.  Lidocaine Iontophoresis Versus Eutectic Mixture of Local Anesthetics (EMLA®) for IV Placement in Children , 2002, Anesthesia and analgesia.

[98]  R H Guy,et al.  Reverse iontophoretic monitoring in premature neonates: feasibility and potential. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[99]  P. McGrath,et al.  Use of lidocaine-prilocaine patch to decrease intramuscular injection pain does not adversely affect the antibody response to diphtheria-tetanus-acellular pertussis-inactivated poliovirus -Haemophilus influenzae type b conjugate and hepatitis B vaccines in infants from birth to six months of age , 2002, The Pediatric infectious disease journal.

[100]  P. Hoeger,et al.  Skin Physiology of the Neonate and Young Infant: A Prospective Study of Functional Skin Parameters During Early Infancy , 2002, Pediatric dermatology.

[101]  R. Chiavacci,et al.  A Study of Lidocaine Iontophoresis for Pediatric Venipuncture , 2002, Anesthesia and analgesia.

[102]  P. Hoeger,et al.  Epidermal barrier lipids in human vernix caseosa: corresponding ceramide pattern in vernix and fetal skin , 2002, The British journal of dermatology.

[103]  G. Finley,et al.  A randomized double‐blind, placebo‐controlled trial of the EMLA® patch for the reduction of pain associated with intramuscular injection in four to six‐year‐old children , 2001, Acta paediatrica.

[104]  Yuan-chi Lin.  Anisocoria from transdermal scopolamine , 2001, Paediatric anaesthesia.

[105]  C. Ankarberg-Lindgren,et al.  Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen at the onset of spontaneous puberty in girls. , 2001, The Journal of clinical endocrinology and metabolism.

[106]  A. Goldman,et al.  Transdermal fentanyl for pain relief in a paediatric palliative care population , 2001, Palliative medicine.

[107]  J. Silverstein,et al.  Clinical testing results and high patient satisfaction with a new needle-free device for growth hormone in young children , 2001, Endocrine.

[108]  S. K. Szabo,et al.  Significant absorption of topical tacrolimus in 3 patients with Netherton syndrome. , 2001, Archives of dermatology.

[109]  S. Seidenari,et al.  Skin Barrier, Hydration, and pH of the Skin of Infants Under 2 Years of Age , 2001, Pediatric dermatology.

[110]  J. Levron,et al.  Pharmacokinetics of transdermal fentanyl in the peri‐operative period in young children , 2000, Anaesthesia.

[111]  P. McGrath,et al.  Lidocaine-prilocaine patch decreases the pain associated with the subcutaneous administration of measles-mumps-rubella vaccine but does not adversely affect the antibody response. , 2000, The Journal of pediatrics.

[112]  K. Kirchhoff,et al.  Comparing two methods of topical anesthesia used before intravenous cannulation in pediatric patients. , 2000, Journal of pediatric health care : official publication of National Association of Pediatric Nurse Associates & Practitioners.

[113]  M. Ferguson,et al.  Barrier formation in the human fetus is patterned. , 1999, The Journal of investigative dermatology.

[114]  J. Swanson,et al.  A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[115]  R. Portenoy,et al.  Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates. , 1999, The Journal of pediatrics.

[116]  S. Dinh,et al.  Transdermal iontophoretic delivery of methylphenidate HCl in vitro. , 1999, International journal of pharmaceutics.

[117]  B. Bar‐Oz,et al.  Coma in a premature infant associated with the transdermal absorption of propylene glycol , 1998, Acta paediatrica.

[118]  Y. Kalia,et al.  Development of skin barrier function in premature infants. , 1998, The Journal of investigative dermatology.

[119]  K. Anand,et al.  Lidocaine iontophoresis for topical anesthesia before intravenous line placement in children. , 1998, The Journal of pediatrics.

[120]  A. Finlay,et al.  A practical guide to topical therapy in children , 1998, The British journal of dermatology.

[121]  V. Nadkarni,et al.  Clonidine prophylaxis for narcotic and sedative withdrawal syndrome following laryngotracheal reconstruction. , 1998, Archives of otolaryngology--head & neck surgery.

[122]  R. Guy,et al.  Iontophoretic transport pathways: dependence on penetrant physicochemical properties. , 1997, Journal of pharmaceutical sciences.

[123]  P. Mulder,et al.  Prilocaine/lidocaine patch as a local premedication for skin biopsy in children. , 1997, Journal of the American Academy of Dermatology.

[124]  L. Germain,et al.  From newborn to adult: Phenotypic and functional properties of skin equivalent and human skin as a function of donor age , 1997, Journal of cellular physiology.

[125]  G. Bernini,et al.  Comparison of Two Application Techniques of EMLA and Pain Assessment in Pediatric Oncology Patients , 1996, Regional Anesthesia & Pain Medicine.

[126]  Gregorios G Agyralides,et al.  Development and in vitro evaluation of furosemide transdermal formulations using experimental design techniques. , 1995, International journal of pharmaceutics.

[127]  M. Ebisawa,et al.  Pharmacokinetics and pharmacodynamics of the tulobuterol patch, HN-078, in childhood asthma. , 1995, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[128]  P. Smyth,et al.  Hypothyroidism secondary to topical iodine treatment in infants with spina bifida , 1994, Acta paediatrica.

[129]  A. Rotstein,et al.  The EMLA patch—a new type of local anaesthetic application for dermal analgesia in children , 1994, Anaesthesia.

[130]  D. West,et al.  In vitro percutaneous absorption evaluation of phenobarbital through hairless mouse, adult and premature human skin , 1993 .

[131]  G. Micali,et al.  Evaluation of Transdermal Theophylline Pharmacokinetics in Neonates , 1993, Pharmacotherapy.

[132]  M. Turpeinen,et al.  Transepidermal water loss and absorption of hydrocortisone in widespread dermatitis , 1993, The British journal of dermatology.

[133]  N. Rutter,et al.  An in Vitro Study of Diamorphine Permeation Through Premature Human Neonatal Skin , 1993, Pharmaceutical Research.

[134]  A. Sola,et al.  Treatment of peripheral tissue ischemia with topical nitroglycerin ointment in neonates. , 1992, The Journal of pediatrics.

[135]  P. Hüppi,et al.  Developmental Aspects of Percutaneous Caffeine Absorption in Premature Infants , 1992, American journal of perinatology.

[136]  P. Plantin,et al.  [Variations of the skin permeability in premature newborn infants. Value of the skin vasoconstriction test with neosynephrine]. , 1992, Archives francaises de pediatrie.

[137]  Russell O. Potts,et al.  Predicting Skin Permeability , 1992, Pharmaceutical Research.

[138]  P. Hüppi,et al.  Percutaneous caffeine application in the treatment of neonatal apnoea , 1991, European Journal of Pediatrics.

[139]  Y. Horimoto,et al.  Scopolamine patch reduces postoperative emesis in paediatric patients following strabismus surgery , 1991, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[140]  M. Turpeinen.  Absorption of hydrocortisone from the skin reservoir in atopic dermatitis , 1991, The British journal of dermatology.

[141]  L. Zeltzer,et al.  Iontophoresis versus subcutaneous injection: a comparison of two methods of local anesthesia delivery in children , 1991, Pain.

[142]  J. Ramet,et al.  Transdermal trinitrine therapy in the pediatric age group considerations about the local application of trinitrine ointment as an aid to venipuncture , 1990 .

[143]  W. Good,et al.  Epidermal Differentiation and Permeability in Fetal Pig Skin , 1990, Pharmaceutical Research.

[144]  N. Rutter,et al.  Transdermal delivery of theophylline to premature infants using a hydrogel disc system. , 1990, British journal of clinical pharmacology.

[145]  G. Merenstein,et al.  Transcutaneous theophylline collection in preterm infants , 1990, Clinical pharmacology and therapeutics.

[146]  M. Lhermitte,et al.  [Efficacy of percutaneous caffeine in the treatment of apnea in the premature infant]. , 1990, Archives francaises de pediatrie.

[147]  G. Vaksmann,et al.  [Value of percutaneous trinitrin to facilitate access to the peripheral venous system in infants]. , 1989, Archives francaises de pediatrie.

[148]  T. Wong,et al.  Transdermal Drug Delivery , 1989 .

[149]  M. Turpeinen,et al.  Percutaneous Absorption of Hydrocortisone During and After the Acute Phase of Dermatitis in Children , 1988, Pediatric dermatology.

[150]  J. Hadgraft,et al.  Percutaneous Absorption in Preterm Infants , 1987, Pediatric dermatology.

[151]  M. Turpeinen,et al.  Effect of percutaneous absorption of hydrocortisone on adrenocortical responsiveness in infants with severe skin disease , 1986, The British journal of dermatology.

[152]  J. Hadgraft,et al.  Percutaneous administration of theophylline in the preterm infant. , 1985, The Journal of pediatrics.

[153]  R. Guy,et al.  Transdermal drug delivery to neonates , 1985 .

[154]  V. Harpin,et al.  Barrier properties of the newborn infant's skin. , 1983, The Journal of pediatrics.

[155]  K Hammarlund,et al.  TRANSEPIDERMAL WATER LOSS IN FULL‐TERM AND PRE‐TERM INFANTS , 1983, Acta paediatrica Scandinavica. Supplement.

[156]  V. Harpin,et al.  Percutaneous alcohol absorption and skin necrosis in a preterm infant. , 1982, Archives of disease in childhood.

[157]  G. Sedin,et al.  TRANSEPIDERMAL WATER LOSS IN NEWBORN INFANTS , 1982, Acta paediatrica Scandinavica.

[158]  P. Aggett,et al.  Percutaneous absorption of chlorhexidine in neonatal cord care. , 1981, Archives of disease in childhood.

[159]  G. Sedin,et al.  TRANSEPIDERMAL WATER LOSS IN NEWBORN INFANTS: IV. Small for Gestational Age Infants , 1980, Acta paediatrica Scandinavica.

[160]  B. Cockrell,et al.  The effects of daily bathing of neonatal rhesus monkeys with an antimicrobial skin cleanser containing chlorhexidine gluconate. , 1980, Toxicology and applied pharmacology.

[161]  G. Sedin,et al.  TRANSEPIDERMAL WATER LOSS IN NEWBORN INFANTS II. Relation to Activity and Body Temperature , 1979, Acta paediatrica Scandinavica.

[162]  W. Oh,et al.  Combined effect of radiant warmer and phototherapy on insensible water loss in low-birth-weight infants. , 1979, The Journal of pediatrics.

[163]  J. Mcainsh,et al.  Absorption of chlorhexidine from the intact skin of newborn infants. , 1979, Archives of disease in childhood.

[164]  T. Yeh,et al.  Reduction of insensible water loss in premature infants under the radiant warmer. , 1979, The Journal of pediatrics.

[165]  M. Ohkido,et al.  STUDIES ON SKIN SURFACE BARRIER FUNCTIONS—SKIN SURFACE LIPIDS AND TRANSEPIDERMAL WATER LOSS IN ATOPIC SKIN DURING CHILDHOOD— , 1978, The Journal of dermatology.

[166]  T. Abe.  Studies on skin surface barrier functions. Transepidermal water loss and skin surface lipids during childhood. , 1978, Chemical & pharmaceutical bulletin.

[167]  G. Sedin,et al.  TRANSEPIDERMAL WATER LOSS IN NEWBORN INFANTS I. Relation to Ambient Humidity and Site of Measurement and Estimation of Total Transepidermal Water Loss , 1977, Acta paediatrica Scandinavica.

[168]  J. Hodgman,et al.  Insensible water loss in preterm infants: changes with postnatal development and non-ionizing radiant energy. , 1974, Pediatrics.

[169]  W. Oh,et al.  Effects of radiant warmer on insensible water loss in newborn infants. , 1974, American journal of diseases of children.

[170]  A. Fanaroff,et al.  Insensible water loss in low birth weight infants. , 1972, Pediatrics.

[171]  N. Esterly,et al.  Increased skin permeability in preterm infants , 1971, Pediatric Research.

[172]  J. Keipert.  THE ABSORPTION OF TOPICAL CORTICOSTEROIDS, WITH PARTICULAR REFERENCE TO PERCUTANEOUS ABSORPTION IN INFANCY AND CHILDHOOD , 1971, The Medical journal of Australia.

[173]  V. James,et al.  Effect of potent topical steroids on plasma-cortisol levels of infants and children with eczema. , 1969, Lancet.

[174]  E. Bruck,et al.  Percutaneous absorption of hydrocortisone in children. , 1966, American journal of diseases of children.

[175]  Y. Takema,et al.  Developmental alterations of physical properties and components of neonatal-infantile stratum corneum of upper thighs and diaper-covered buttocks during the 1st year of life. , 2014, Journal of dermatological science.

[176]  Raul R. Silva.  Methylphenidate Transdermal System In Attention-Deficit Hyperactivity Disorder in Children , 2012, Drugs.

[177]  S. Aucott,et al.  Safety of chlorhexidine gluconate used for skin antisepsis in the preterm infant , 2012, Journal of Perinatology.

[178]  E. Prommer,et al.  Fentanyl (transmucosal). , 2012, Journal of pain and symptom management.

[179]  M. Delgado-Charro.  Sampling substrates by skin permeabilization , 2011 .

[180]  J. Croxtall.  In Minor Dermatological and Needle Puncture Procedures , 2010 .

[181]  M. Delgado-Charro.  Recent advances on transdermal iontophoretic drug delivery and non-invasive sampling , 2009 .

[182]  C. Gordon,et al.  Transdermal Scopolamine for Prevention of Motion Sickness , 2006, Clinical pharmacokinetics.

[183]  W. Sterry,et al.  Variations of hair follicle size and distribution in different body sites. , 2004, The Journal of investigative dermatology.

[184]  Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network. , 2004, Diabetes care.

[185]  U. Blume-Peytavi,et al.  Stratum corneum maturation. A review of neonatal skin function. , 2004, Skin pharmacology and physiology.

[186]  J. Samet,et al.  Food and Drug Administration , 2007, BMJ : British Medical Journal.

[187]  M. Dixit,et al.  Treatment of chronic hypertension with intravenous enalaprilat and transdermal clonidine , 2001, Pediatric Nephrology.

[188]  J. Broderick-Cantwell,et al.  Case study: accidental clonidine patch overdose in attention-deficit/hyperactivity disorder patients. , 1999, Journal of the American Academy of Child and Adolescent Psychiatry.

[189]  “ Inactive ” Ingredients in Pharmaceutical Products : Update ( Subject Review ) , 1998 .

[190]  P. Sanberg,et al.  Transdermal Nicotine in Tourette’s Syndrome , 1995 .

[191]  F. Greig,et al.  Decreased T3 and T4 Levels Following Topical Application of Povidone-Iodine in Premature Neonates , 1994, The Journal of pediatric endocrinology.

[192]  N. Morton,et al.  Prevention of postoperative nausea and vomiting with transdermal hyoscine in children using patient-controlled analgesia. , 1994, British journal of anaesthesia.

[193]  D. Steward,et al.  A multicentre randomized study of single-unit dose package of EMLA patch vs EMLA 5% cream for venepuncture in children , 1994, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[194]  N. Rutter,et al.  Transdermal delivery and the premature neonate. , 1994, Critical reviews in therapeutic drug carrier systems.

[195]  M. Levene,et al.  Development of the Transdermal Potential of Human Skin , 1991, Pediatric Research.

[196]  P. O’Connell,et al.  Clonidine in child and adolescent psychiatry. , 1990, Journal of child and adolescent psychopharmacology.

[197]  J. Ramet,et al.  [Critical study of efficiency and toxicity of transcutaneous trinitrin in infants and children]. , 1990, Pediatrie.

[198]  R. D. Hunt.  Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H. , 1987, Psychopharmacology bulletin.

[199]  Hunt Rd.  Treatment effects of oral and transdermal clonidine in relation to methylphenidate: an open pilot study in ADD-H. , 1987 .

[200]  N. Evans,et al.  Development of the epidermis in the newborn. , 1986, Biology of the neonate.

[201]  H. Maibach,et al.  Transepidermal water loss in vivo. Premature and term infants. , 1980, Biology of the neonate.

[202]  H. Maibach,et al.  Skin Barrier Properties in the Newborn , 1977 .

[203]  H. Maibach,et al.  Skin barrier properties in the newborn. Transepidermal water loss and carbon dioxide emission rates. , 1977, Biology of the neonate.

[204]  A. Kolpakova,et al.  [The skin barrier]. , 1972, Vestnik dermatologii i venerologii.

[205]  R. Kimbrough,et al.  Dermal absorption of hexochlorophane in infants. , 1971, Lancet.